2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow ISIS 416858: new trials by email Literature Review of ISIS 416858 trials Research Report on ISIS 416858
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis ISIS 416858, Placebo - End-stage Renal Disease (ESRD) | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 213 | 2017-12-26 | 2023-01-20 |
| A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis ISIS 416858, Placebo - End-stage Renal Disease (ESRD) | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 49 | 2015-10-01 | 2016-12-13 |
Ionis Pharmaceuticals, Inc. (2)
Canada (1) · Spain (1)
2017 (1)